Adial Pharmaceuticals Inc ADIL:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:59 PM EDT
3.02quote price arrow down-0.11 (-3.51%)
Volume
81,676
Close
3.13quote price arrow up+0.26 (+9.06%)
Volume
21,939,710
52 week range
1.14 - 4.00

...

Loading . . .
  • Open3.52
  • Day High3.78
  • Day Low2.97
  • Prev Close2.87
  • 52 Week High4.00
  • 52 Week High Date09/29/20
  • 52 Week Low1.14
  • 52 Week Low Date09/24/20

Key Stats

  • Market Cap54.78M
  • Shares Out17.50M
  • 10 Day Average Volume0.64M
  • Dividend-
  • Dividend Yield-
  • Beta0.61
  • YTD % Change84.12

KEY STATS

  • Open3.52
  • Day High3.78
  • Day Low2.97
  • Prev Close2.87
  • 52 Week High4.00
  • 52 Week High Date09/29/20
  • 52 Week Low1.14
  • 52 Week Low Date09/24/20
  • Market Cap54.78M
  • Shares Out17.50M
  • 10 Day Average Volume0.64M
  • Dividend-
  • Dividend Yield-
  • Beta0.61
  • YTD % Change84.12

RATIOS/PROFITABILITY

  • EPS (TTM)-0.95
  • P/E (TTM)-3.30
  • Fwd P/E (NTM)-5.40
  • EBITDA (MRQ)-13.467M
  • ROE (MRQ)-240.84%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.52%

EVENTS

  • Earnings Date08/14/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Adial Pharmaceuticals Inc

There is no recent news for this security.

Profile

MORE
Adial Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of medications for the treatment of addictions and related disorders. Its lead investigational drug product is AD04. AD04 is being developed for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist. AD04 is being designed to be used for the treatment of other addictive disorders, such as opioid use...
Kevin Schuyler
Vice Chairman
William Stilley III
President
Joseph Truluck
Chief Financial Officer
Address
1180 SEMINOLE TRAIL, SUITE 495
Charlottesville, VA
22901
United States

Top Peers

SYMBOLLASTCHG%CHG
CATB
Catabasis Pharmaceuticals Inc
1.94-0.06-3.00%
CNSP
CNS Pharmaceuticals Inc
2.07+0.02+0.98%
ACHV
Achieve Life Sciences Inc
7.93+0.31+4.07%
IDRA
Idera Pharmaceuticals Inc
1.58+0.46+41.07%
OCUP
Ocuphire Pharma Inc
4.76-0.16-3.25%